SCYNEXIS, Inc. to Present at 35th Canaccord Genuity Annual Growth Conference
August 10, 2015 08:30 ET
|
SCYNEXIS, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 10, 2015 (GLOBE NEWSWIRE) -- Drug development company SCYNEXIS, Inc. (Nasdaq:SCYX) today announced that Marco Taglietti, M.D., SCYNEXIS' Chief Executive Officer,...
SCYNEXIS, Inc. to Focus on SCY-078 Development
July 23, 2015 08:30 ET
|
SCYNEXIS, Inc.
RESEARCH TRIANGLE PARK, N.C., July 23, 2015 (GLOBE NEWSWIRE) -- Drug discovery and development company SCYNEXIS, Inc. (Nasdaq:SCYX) today announced that it has completed an asset purchase agreement...
SCYNEXIS, Inc. to Present at 10th Annual JMP Securities Life Sciences Conference
June 18, 2015 08:30 ET
|
SCYNEXIS, Inc.
RESEARCH TRIANGLE PARK, N.C., June 18, 2015 (GLOBE NEWSWIRE) -- Drug discovery and development company SCYNEXIS, Inc. (Nasdaq:SCYX) today announced that David Angulo, M.D., SCYNEXIS' Chief Medical...
SCYNEXIS, Inc. Announces Changes to Board of Directors
June 10, 2015 08:30 ET
|
SCYNEXIS, Inc.
RESEARCH TRIANGLE PARK, N.C., June 10, 2015 (GLOBE NEWSWIRE) -- Drug discovery and development company SCYNEXIS, Inc. (Nasdaq:SCYX) today announced the following changes to its Board of...
SCYNEXIS, Inc. Announces New Employment Inducement Grant
June 05, 2015 08:30 ET
|
SCYNEXIS, Inc.
RESEARCH TRIANGLE PARK, N.C., June 5, 2015 (GLOBE NEWSWIRE) -- Drug discovery and development company SCYNEXIS, Inc. (Nasdaq:SCYX) today announced that on June 4, 2015, new employee David Angulo,...
SCYNEXIS, Inc. to Present at Jefferies 2015 Healthcare Conference
May 26, 2015 08:30 ET
|
SCYNEXIS, Inc.
RESEARCH TRIANGLE PARK, N.C., May 26, 2015 (GLOBE NEWSWIRE) -- Drug discovery and development company SCYNEXIS, Inc. (Nasdaq:SCYX) today announced that Marco Taglietti, M.D., SCYNEXIS' Chief Executive...
SCYNEXIS, Inc. Reports First Quarter 2015 Financial Results
May 15, 2015 08:30 ET
|
SCYNEXIS, Inc.
RESEARCH TRIANGLE PARK, N.C., May 15, 2015 (GLOBE NEWSWIRE) -- Drug discovery and development company SCYNEXIS, Inc. (Nasdaq:SCYX) today reported financial results for the first quarter of 2015.
"We...
SCYNEXIS Appoints David Angulo, M.D., as Chief Medical Officer
May 14, 2015 08:30 ET
|
SCYNEXIS, Inc.
RESEARCH TRIANGLE PARK, N.C., May 14, 2015 (GLOBE NEWSWIRE) -- Drug discovery and development company SCYNEXIS, Inc. (Nasdaq:SCYX) today announced the appointment of David Angulo, M.D., as Chief...
SCYNEXIS Announces Pricing of Public Offering of Common Stock
April 22, 2015 22:30 ET
|
SCYNEXIS, Inc.
RESEARCH TRIANGLE PARK, N.C., April 22, 2015 (GLOBE NEWSWIRE) -- Drug discovery and development company SCYNEXIS, Inc. (Nasdaq:SCYX) today announced the pricing of its underwritten public offering of...
SCYNEXIS Announces Launch of Public Offering of Common Stock
April 20, 2015 07:40 ET
|
SCYNEXIS, Inc.
RESEARCH TRIANGLE PARK, N.C., April 20, 2015 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq:SCYX) today announced the commencement of an underwritten public offering of shares of its common stock and...